Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future

Katerina M. Antoniou, George A. Margaritopoulos, Nikos M. Siafakas
European Respiratory Review 2013 22: 281-291; DOI: 10.1183/09059180.00002113
Katerina M. Antoniou
Interstitial Lung Disease Unit, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kantoniou@med.uoc.gr
George A. Margaritopoulos
Interstitial Lung Disease Unit, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikos M. Siafakas
Interstitial Lung Disease Unit, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 22 no. 129 281-291
DOI 
https://doi.org/10.1183/09059180.00002113
PubMed 
23997056

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received April 3, 2013
  • Accepted May 13, 2013
  • Published online August 30, 2013.

Copyright & Usage 
©ERS 2013

Author Information

  1. Katerina M. Antoniou⇑,
  2. George A. Margaritopoulos and
  3. Nikos M. Siafakas
  1. Interstitial Lung Disease Unit, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.
  1. K.M. Antoniou, Dept of Thoracic Medicine, University of Crete, Medical School, 71110 Heraklion, Crete, Greece. E-mail: kantoniou{at}med.uoc.gr
View Full Text

Article usage

Article usage: August 2013 to February 2023

AbstractFullPdf
Aug 2013171955
Sep 20131369578561
Oct 20131197494358
Nov 2013749240206
Dec 2013186105122
Jan 20141879898
Feb 20141569198
Mar 20141657082
Apr 2014173131104
May 20149511799
Jun 20149211374
Jul 20149112467
Aug 2014698557
Sep 2014707451
Oct 2014748179
Nov 2014677491
Dec 2014595660
Jan 2015536561
Feb 2015656250
Mar 2015806249
Apr 2015567152
May 2015574332
Jun 2015586634
Jul 2015576037
Aug 2015515433
Sep 2015276445
Oct 201537231
Nov 2015106734
Dec 201584622
Jan 2016166520
Feb 201685627
Mar 2016149529
Apr 2016196032
May 201695122
Jun 201696319
Jul 201665027
Aug 201685429
Sep 2016274220
Oct 2016207318
Nov 2016197430
Dec 20161827216
Jan 2017212218
Feb 201716369
Mar 201721459
Apr 201772210
May 2017103811
Jun 2017133211
Jul 2017153510
Aug 201764413
Sep 201745410
Oct 2017106217
Nov 201728419
Dec 2017227010
Jan 2018749514
Feb 2018240110
Mar 201873538
Apr 201802229
May 2018725313
Jun 2018430511
Jul 2018320614
Aug 2018101468
Sep 201821448
Oct 201812666
Nov 201803565
Dec 201803577
Jan 201911135
Feb 20190956
Mar 201969313
Apr 201945512
May 20192706
Jun 201927710
Jul 201937917
Aug 201958910
Sep 2019520716
Oct 201958914
Nov 20193899
Dec 201926914
Jan 20205616
Feb 202035511
Mar 2020122065
Apr 20201643
May 202066112
Jun 202014510
Jul 20204469
Aug 202055417
Sep 202047817
Oct 2020110819
Nov 2020111516
Dec 2020110317
Jan 202118826
Feb 202114218
Mar 202177024
Apr 2021108418
May 2021311324
Jun 202158611
Jul 202146215
Aug 202147017
Sep 202146512
Oct 202157731
Nov 202166619
Dec 2021412621
Jan 202224612
Feb 202216011
Mar 202237214
Apr 202274732
May 202225224
Jun 202264527
Jul 202255610
Aug 20223218
Sep 202225419
Oct 202233510
Nov 20226324
Dec 2022101617
Jan 20233137
Feb 20230730

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 22 Issue 129 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
Katerina M. Antoniou, George A. Margaritopoulos, Nikos M. Siafakas
European Respiratory Review Sep 2013, 22 (129) 281-291; DOI: 10.1183/09059180.00002113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
Katerina M. Antoniou, George A. Margaritopoulos, Nikos M. Siafakas
European Respiratory Review Sep 2013, 22 (129) 281-291; DOI: 10.1183/09059180.00002113
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Introduction
    • Completed clinical trials
    • Ongoing clinical trials
    • Treatment of IPF: from 2000 to 2011 and beyond
    • Design of clinical trials
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society